fendiline has been researched along with Esophageal Achalasia in 1 studies
Fendiline: Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.
Esophageal Achalasia: A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER (near the CARDIA) fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus (megaesophagus).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stepenko, AS | 1 |
| Nechaev, VM | 1 |
1 other study available for fendiline and Esophageal Achalasia
| Article | Year |
|---|---|
[Effect of calcium antagonists on esophageal motor activity in cardial achalasia].
Topics: Adult; Calcium Channel Blockers; Drug Evaluation; Esophageal Achalasia; Esophagus; Female; Fendiline | 1988 |